Montreux, Switzerland | August 26, 2021 – MedXCell SA, a Swiss biotech company dedicated to transforming healthcare through the development and production of affordable and accessible new
Montreux, Switzerland | June 4, 2021 – MedXCell SA, a Swiss biotech company dedicated to transforming healthcare through the development and production of affordable and
Montreux, Switzerland | May 17, 2021 – MedXCell SA, a Swiss biotech company dedicated to transforming healthcare through the development and production of affordable and
Montreux, Switzerland | April 27, 2021 – The MedXCell Group is proud to announce its participation in the Med Vallée project. This European scale project aims
Montreux, Switzerland | April 14, 2021 – The MedXCell Group is proud to announce the historic entry of the University of Montpellier (UM) into the
Montreux, Switzerland | March 1st, 2021 – MedXCell SA, a Swiss biotech portfolio company dedicated to transforming healthcare through the development and production of innovative,
This website contains information about products that may not be available in all countries, available under different trademarks or for different indications. Nothing contained herein should be considered a solicitation, promotion or advertisement for any product including those under development and described on this site. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider
© All rights reserved 2021 – MedXCell SA
